Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis

• Author(s): Martinelli, Ana de Lourdes Candolo
• Date: 2016
• Origin: Oasisbr
• Subject(s): ANTIVIRAIS
• Document Type: Other
• Language: English